JP2023539940A5 - - Google Patents

Info

Publication number
JP2023539940A5
JP2023539940A5 JP2023515621A JP2023515621A JP2023539940A5 JP 2023539940 A5 JP2023539940 A5 JP 2023539940A5 JP 2023515621 A JP2023515621 A JP 2023515621A JP 2023515621 A JP2023515621 A JP 2023515621A JP 2023539940 A5 JP2023539940 A5 JP 2023539940A5
Authority
JP
Japan
Prior art keywords
sprayable aqueous
composition according
intranasal composition
aqueous intranasal
sprayable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023515621A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539940A (ja
JP7821168B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/074417 external-priority patent/WO2022053412A1/en
Publication of JP2023539940A publication Critical patent/JP2023539940A/ja
Publication of JP2023539940A5 publication Critical patent/JP2023539940A5/ja
Application granted granted Critical
Publication of JP7821168B2 publication Critical patent/JP7821168B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023515621A 2020-09-08 2021-09-03 感染を防止するための組成物 Active JP7821168B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063075590P 2020-09-08 2020-09-08
US63/075,590 2020-09-08
US202063119237P 2020-11-30 2020-11-30
US63/119,237 2020-11-30
US202163173816P 2021-04-12 2021-04-12
US63/173,816 2021-04-12
US202163230191P 2021-08-06 2021-08-06
US63/230,191 2021-08-06
PCT/EP2021/074417 WO2022053412A1 (en) 2020-09-08 2021-09-03 Compositions for preventing infection

Publications (3)

Publication Number Publication Date
JP2023539940A JP2023539940A (ja) 2023-09-20
JP2023539940A5 true JP2023539940A5 (https=) 2024-09-11
JP7821168B2 JP7821168B2 (ja) 2026-02-26

Family

ID=77864552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023515621A Active JP7821168B2 (ja) 2020-09-08 2021-09-03 感染を防止するための組成物

Country Status (7)

Country Link
US (2) US12280142B2 (https=)
EP (1) EP4210670A1 (https=)
JP (1) JP7821168B2 (https=)
AU (1) AU2021338957A1 (https=)
CA (1) CA3174314A1 (https=)
TW (1) TW202227104A (https=)
WO (1) WO2022053412A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202227104A (zh) 2020-09-08 2022-07-16 瑞士商艾爾塔米拉醫療有限公司 預防感染之組合物
US20260041706A1 (en) * 2022-08-04 2026-02-12 The Brigham And Women's Hospital, Inc. Mucus membrane formulations and uses thereof
WO2026010400A1 (ko) * 2024-07-03 2026-01-08 (주)시지바이오 스프레이형 점착성 점막 창상피복재

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC2204A1 (fr) 1989-10-31 1992-11-26 Columbia Lab Inc Composition et methode d'humidification de tissus
IT1275955B1 (it) 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
WO1996039031A1 (en) 1995-06-06 1996-12-12 Kimberly-Clark Worldwide, Inc. Microporous film containing a microbial adsorbent
US20020009478A1 (en) 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
US6183766B1 (en) 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
DE10064950A1 (de) 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
MXPA04011584A (es) * 2002-05-23 2005-03-31 Umd Inc Composiciones y metodo para la administracion y crioproteccion de drogas transmucosales.
EP1374856A1 (en) 2002-06-18 2004-01-02 Impetus AG Oily thixotropic nasal spray
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20070031512A1 (en) 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
US20070202055A1 (en) 2006-02-09 2007-08-30 Julianne Berry Pharmaceutical Formulations
KR101437708B1 (ko) 2006-12-05 2014-09-03 마리노메드 바이오테크놀로지 게엠베하 항바이러스 조성물과 이의 이용 방법
HRP20130402T1 (hr) 2007-08-24 2013-06-30 Marinomed Biotechnologie Gmbh Antivirusni pripravak koji sadrži sulfatirani polisaharid: jota-karagenan
WO2011029218A1 (zh) 2009-09-09 2011-03-17 济南康众医药科技开发有限公司 蒙脱石在制备药物中的应用
FR2954707B1 (fr) 2009-12-28 2016-01-08 Diffusion Tech Francaise Sarl Dispositif d'administration d'aerosol par voie buccale a visee rhinopharyngee, nasale ou nasosinusienne
WO2012067932A1 (en) 2010-11-19 2012-05-24 Milestone Scientific, Inc. A novel antimicrobial barrier and methods of use thereof to prevent sexually transmitted disease
US20140051732A1 (en) 2011-04-19 2014-02-20 Arm Pharmaceutical Llc Low-tack surface anti-microbial coating composition and method of application
WO2012145307A1 (en) 2011-04-19 2012-10-26 Brian Sokol Method of inhibiting harmful microorganisms and barrier-forming composition therefor
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
KR101474858B1 (ko) 2013-04-26 2014-12-19 리드메디 (주) 무방부제 약제를 위생적으로 보관하기 위한 필터부재를 갖는 비강 스프레이 장치
US10398465B2 (en) 2014-04-29 2019-09-03 Misonix Incorporated Ultrasonic surgical instrument assembly, related accessory, and associated surgical method
WO2015174910A1 (en) * 2014-05-13 2015-11-19 Aerosol Scandinavia Ab Composition having improved spraying characteristics comprising vegetable oils and triglycerides and/or mineral oils
ES2802530T3 (es) 2015-08-04 2021-01-20 Windstar Medical Gmbh Una composición nasal
TW202227104A (zh) 2020-09-08 2022-07-16 瑞士商艾爾塔米拉醫療有限公司 預防感染之組合物

Similar Documents

Publication Publication Date Title
JP2023539940A5 (https=)
JP2004525903A5 (https=)
HRP20130052T1 (hr) Lijeäśenje respiratorne bolesti
JP2004505046A5 (https=)
JP2774379B2 (ja) 医薬エアロゾール組成物ならびにそれらのウイルス疾患の治療および予防用途
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
US20260007596A1 (en) Compositions for preventing infection
US20230075885A1 (en) Compositions and applications thereof
JP2016147914A (ja) 上気道の疾患およびインフルエンザ症候群を治療するための組成物
HRP20160373T1 (hr) Kombinacija antikolinergika i antagonista leukotrien receptora za liječenje bolesti dišnog sustava
CN112791097A (zh) 碘在制备预防、治疗呼吸道感染性疾病的药物中的应用以及制备低粒径含碘气溶胶的方法
US20230218557A1 (en) A fatty acid based composition for treatment and/or prevention of enveloped-virus related infections
CN103720650A (zh) 一种具有抗流感病毒作用的黄芩苷注射剂
US20240165191A1 (en) Compositions and methods for reducing the transmissivity of illnesses using an oral delivery system
CN117083057A (zh) 用于预防感染的组合物
US20230158067A1 (en) Silver nanoparticles for use in inhibiting and treating coronavirus infection
Go et al. Intranasal therapy and COVID-19: A comprehensive literature review
AU2017294686B2 (en) Use of xibornol as active agent in the treatment of viral infections
CN105902534A (zh) 苯酚茶酸素在制备治疗或预防呼吸系统疾病药物中的应用
US20240173387A1 (en) Peptidase formulation for treatment of microbial infections in the upper respiratory tract
JP2024547022A5 (https=)
IT202200020580A1 (it) Composizione di prodotto finito comprendente estratti naturali avente attività antivirale in grado di inibire la proteina spike di virus quali coronavirus, e suoi usi
WO2025245573A1 (en) Formulation and hydrogels formed therefrom
EP4734956A1 (en) Mucoadhesive formulation
FI3870226T3 (fi) Mukoadhesiivisia kortikosteroidien farmaseuttisia koostumuksia